Therefore, we aimed to establish a highly sensitive time‐resolved fluorescence immunoassay (TRFIA)14 and evaluate its application for detecting IL‐18 in the serum of liver cancer, hepatitis B, hepatitis C, autoimmune hepatitis, and fatty liver disease patients. This evidence concerns the gene IL18 and autoimmune hepatitis.